chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling
Clinical narrative: muscle pain; muscle cramps; chills; had terrible pain in her foot; severe pain in her heel and arch; swelling; This is a spontaneous report received from a contactable consumer or other non hcp. An 87-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EM9810) via an unspecified route of administration on 06Feb2021 (at the age of 87-year-old) as a single dose for COVID-19 immunization. Medical his-tory included drug hypersensitivity from an unknown date and unknown if ongoing. Concomitant medication(s) included allopurinol (ALLOPURINOL) taken for an unspecified indication, start and stop date were not reported. The patient experienced had terrible pain in her foot, severe pain in her heel and arch, swelling on 10Feb2021, and muscle pain, muscle cramps, chills on an unspecified date. Additional information she received first dose on 6Feb2021 and 4 days later had terrible pain in her foot. The swelling and pain were still ongoing.  Any information if this was a side effect and how long it will last and also seeking information how much protection with just first dose. She had such a bad time with her foot. She had muscle pain, muscle cramps and chills she had all of that she had and expected all of those. She went to bed fine, but when she went to get up the next morning, my right foot was swollen and couldn't put any pressure at all. She has lost the use of her right foot. she can't make the steps to her bedroom. She has been down on the couch since the 10Feb2021, the pain isn't as severe as it was early on. It was unbearable pain, 10 out of 10 pains, you couldn't touch the foot at all, pain of a gout, even a blanket hurt. It has lessened gradually little every day hoping it goes away completely. she was wondering how long it would last and when can she get use back of my foot because she was very active person before and it's not easy. she still has pain from the arch into heel of the foot. If she doesn't put a sock on it then the toes will fall on each other. (The big toe will go over to the little toe). she doesn't want to subject myself. she can't even put a shoe on to go to the doctors. she stays in the house anyway. The clinical outcome of the event terrible pain in her foot, severe pain in her heel and arch, swelling, muscle pain, were recovering and other events was unknown.  No follow up attempts are possible. no further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Neck pain, Pain in extremity
Clinical narrative: Intense and severe arm, elbow, shoulder and neck pain; Intense and severe arm, elbow, shoulder and neck pain; Intense and severe arm, elbow, shoulder and neck pain; This is a spontaneous report from a contactable consumer (patient). A 38-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Lot Number: not reported), dose 1 via an unspecified route of administration, administered in right arm on 19Feb2021 15:30 (at age of 38-year-old) as dose 1, single for covid-19 immunization at clinic. Medical history included tooth infection (treated with antibiotics), rash (treated with antibiotics). Concomitant medications (within 2 weeks of vaccination) included amoxicillin trihydrate, clavulanate potassium (AMOXICILLIN & CLAV. POTASSIUM). The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 22Feb2021 12:00, the patient experienced intense and severe arm, elbow, shoulder and neck pain. Treatment received as Flexiril muscle relaxers for the adverse events. The outcome of events was recovering.  No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Blood pressure measurement, Body temperature, Diarrhoea, Oxygen saturation
Clinical narrative: Intractable vomiting; diarrhea during 24 hours; severe weakness; This is a spontaneous report from a contactable consumer (patient).    An 82-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: Lot9266, Expiry Date: Not Reported), via an unspecified route, administered in Left arm on 15Feb2021 (at the age of 82-year-old) at 13:00 as dose 2, single for covid-19 immunisation at hospital. The patient was not pregnant at time of vaccination. The patient was not pregnant at the time of vaccination. The patient medical history included breast cancer (Impossible to specify from breast cancer to arthritis and etc), and arthritis (Impossible to specify from breast cancer to arthritis and etc). The patient concomitant medications were not reported. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Lot Number: Not Reported, Expiry Date: Not Reported) via an unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient was not tested for COVID-19 since the vaccination. The patient was allergic to Opioids. On 20Feb2021, that is fifth day after the second vaccine dose, the patient experienced Intractable vomiting and diarrhea during 24 hours, severe weakness. On 21Feb2021 (Next day) vomiting stopped, no stomach on the third day. Severe weakness is continuing. The patient underwent lab tests and procedures which included blood pressure measurement: normal on an unspecified date, body temperature: normal on an unspecified date, oxygen saturation: no lower than 96 percentage on an unspecified date. The patient did not receive any treatment for the reported events. Outcome of the event intractable vomiting was recovered on 21Feb2021 and outcome for rest all events was recovering.  No follow-up attempts are needed. No further information is expected
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Intractable vomiting; diarrhea during 24 hours; severe weakness; This is a spontaneous report from a contactable consumer (patient).    An 82-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: Lot9266, Expiry Date: Not Reported), via an unspecified route, administered in Left arm on 15Feb2021 (at the age of 82-year-old) at 13:00 as dose 2, single for covid-19 immunisation at hospital. The patient was not pregnant at time of vaccination. The patient was not pregnant at the time of vaccination. The patient medical history included breast cancer (Impossible to specify from breast cancer to arthritis and etc), and arthritis (Impossible to specify from breast cancer to arthritis and etc). The patient concomitant medications were not reported. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Lot Number: Not Reported, Expiry Date: Not Reported) via an unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient was not tested for COVID-19 since the vaccination. The patient was allergic to Opioids. On 20Feb2021, that is fifth day after the second vaccine dose, the patient experienced Intractable vomiting and diarrhea during 24 hours, severe weakness. On 21Feb2021 (Next day) vomiting stopped, no stomach on the third day. Severe weakness is continuing. The patient underwent lab tests and procedures which included blood pressure measurement: normal on an unspecified date, body temperature: normal on an unspecified date, oxygen saturation: no lower than 96 percentage on an unspecified date. The patient did not receive any treatment for the reported events. Outcome of the event intractable vomiting was recovered on 21Feb2021 and outcome for rest all events was recovering.  No follow-up attempts are needed. No further information is expected
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain, Pain in extremity
Clinical narrative: Sore arm day after; ached all over; Shivers (cold and hot) felt like a fever; This is a spontaneous report from a contactable consumer (patient). A 87-year-old non pregnant female patient received second dose of bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection; Batch /Lot Number: EL3249), via an unspecified route of administration, administered in Arm Right on 02Feb2021(at the age of 87-years-old) as dose 2 single for covid-19 immunization. Medical history included myocardial infarction, lung neoplasm malignant, hypersensitivity from an un-known date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Historical vaccine received first dose of bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection; Batch/Lot Number: EL3249) via an unspecified route of administration, administered in Arm left on 19Jan2021 as single dose for covid-19 immunization. On 10Feb2021, the patient experienced sore arm day after, ached all over, shivers (cold and hot) felt like a fever. The patient did not receive any treatment for the events. The outcome of sore arm day after, ached all over, shivers (cold and hot) felt like a fever was recovered on an unspecified date in 2021.  Follow-up attempts completed. No further information expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site rash, Miliaria
Clinical narrative: Rashes in the days after the vaccine; Rashes in the days after the vaccine Seems to be related to heat; This is a spontaneous report from a contactable consumer, the patient. A 35-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number: EL9261), via an unspecified route of administration, administered in arm left on 19Feb2021 08:00 as dose 1, single (at the age of 35-years-old) for covid-19 immunization. The patient medical history was not reported. Concomitant medications included ethinylestradiol, norethisterone acetate (JUNEL) and cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]). The patient previously took amoxicillin and experienced hypersensitivity. On 19Feb2021 10:00, the patient experienced rashes in the days after the vaccine and it seems to be related to heat. The patient did not receive any treatment for the events. The patient did not receive any other vaccine in four weeks. The patient had not covid prior to the vaccination and the patient had not tested for covid post vaccination. The outcome of the events was not recovered.  Follow-up attempts completed. No further information expected.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Agitation, Fatigue, Hypoaesthesia
Clinical narrative: Muscles tired; Fatigue; numbness in face; feeling off; This is a spontaneous report from a contactable consumer (patient) or other non HCP.   A 38-years-old male patient received first dose of BNT162B2 (PFIZER BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Batch/Lot Number: Em9809) via unspecified route of administration in Right arm on 14Feb2021 at 08:45 AM as dose 1, single (age at vaccination 38 years old) for covid-19 immunisation. Patient medical history included attention deficit hyperactivity disorder from unknown date. Patient had no known allergies. Patient did not received any other vaccine in four weeks. Patient did not received other medications in two weeks. The patient had not diagnosed with covid prior to vaccination and had not been tested post vaccination. On 23Feb2021 at 12:00 AM patient experienced fatigue, numbness in face, feeling off, muscles tired. Patient did not received treatment for adverse event. The outcome of events were not recovered.  Follow-up attempts completed. No further information expected.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Pain on the injection site; This is a spontaneous report from a contactable physician. A 47-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: not reported, expiration date: not reported) intramuscular, administered in Arm Left on 31Dec2020 09:00 (at the age of 47 years) as dose 1, single for covid-19 immunization in hospital. The patient medical history and concomitant medications were not reported. Patient had no known allergies. Patient did not had any other vaccine in four weeks. Patient was not tested covid post vaccination. Patient had no Covid prior vaccination. On 31Dec2020 16:00, the patient experienced pain on the injection site. Patient did not received any treatment. Clinical outcome of the event was reported as recovered on an unspecified date.  Follow-up attempts completed. No further information expected.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Skin odour abnormal
Clinical narrative: After the first shot I had severely foul underarm odor for about four days; This is a spontaneous report from a contactable consumer or other non hcp (patient).  A 72-years-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiration date were not reported) via an unspecified route of administration, administered in left arm on 24Feb2021 at 16:00 (at the age of 72-years-old) as dose 2, single and first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiration date were not reported) via an unspecified route of administration, administered in left arm on 04Feb2021 in four weeks as dose 1, single for covid-19 immunization. Medical history included spinal stenosis, osteoporosis, scoliosis, start and stop date unknown. Patient had Penicillin allergies. Patient took other medications in two weeks was dietary supplements. On 04Feb2021, patient experienced after the first shot i had severely foul underarm odor for about four days. Patient had not received any treatment. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The outcome of events was unknown.  Follow-up attempts are completed. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Illness, Influenza
Clinical narrative: felt sick; he felt like he had the flu for 3 days after he got the second Pfizer vaccine shot.; This is a spontaneous report from a contactable physician (patient). A male patient of an unspecified age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number was not reported, Expiry date: unknown) via an unspecified route of administration on an unspecified date as dose 2, single for COVID-19 immunization. Patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on unspecified date for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date the patient experienced felt sick, he felt like he had the flu for 3 days after he got the second pfizer vaccine shot. The outcome of events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: arm was a little sore at the site of injection; This is a spontaneous report received from a contactable consumer or other non hcp. A 56-years-old non pregnancy female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/lot number was not reported) via an unspecified route of administration on 24Feb2021 at 09:15AM (age at vaccination 56years old) as single dose for covid-19 immunisation. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested positive for COVID-19. The patient medical history and concomitant medications were not reported. The patient previously took morphine and experienced drug hypersensitivity. On 24Feb2021 the patient experienced arm was a little sore at the site of injection. The patient did not receive any treatment for the adverse events. The clinical outcome of the event was recovering.  Follow-up attempts completed. No further information expected.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Infectious mononucleosis, Pain, Pyrexia, SARS-CoV-1 test
Clinical narrative: active mononucleosis; A fever for 10 days and aches and chills developed 10 days after vaccination; A fever for 10 days and aches and chills developed 10 days after vaccination; A fever for 10 days and aches and chills developed 10 days after vaccination; This is a spontaneous report from a contactable other health care professional (patient). A 44-year-old non-pregnant female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date: unknown) via an unspecified route of administration, administered in arm left on an unknown date in 2021 (at the age of 44-year-old) as dose 1, single for COVID-19 immunization at Hospital. Medical history included asthma from an unknown date and unknown if ongoing. Concomitant medication(s) within two weeks included escitalopram (MANUFACTURER UNKNOWN) taken for an unspecified indication from an unspecified date. Patient had no known allergies. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Patient did not have Covid prior to vaccination and was not tested for it post vaccination. On 19Jan2021 at 12:00, the patient experienced active mononucleosis, a fever for 10 days and aches and chills developed 10 days after vaccination. It was determined to be a reactivated EBV, so active mononucleosis. Adverse event resulted in doctor or other healthcare professional office/clinic visit. The patient underwent lab tests and procedures which included sars-cov-1 test (Nasal Swab): negative on 22Jan2021 and sars-cov-1 test (Nasal Swab): negative on 27Jan2021. Therapeutic measures were taken as a result of the events and patient was given Vitamins and Ibuprofen. The outcome of event was resolving.  Follow-up (19MAY2021): Follow-up attempts completed. No further information expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Dizziness, Fatigue, Headache, Nausea
Clinical narrative: armpit pain starting at 6 days post; dizziness; Arm pain x 7 days post-injection; severe headache; nausea; fatigue; This is a spontaneous report from a contactable pharmacist (patient, self-reported). A 32-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EL9263 and expiry date was not reported), via an unspecified route of administration, in Arm Left, on 18Feb2021 at 16:30 PM, as dose 2, single for COVID-19 immunization at hospital (Age at vaccination: 32 years). The patient was not pregnant at the time of vaccination. The patient medical history included exercise-induced bronchospasm, depression, anxiety and Past drug event with tetracycline and experienced rash. Concomitant medications included ascorbic acid, betacarotene, calcium sulfate, colecalciferol, cyanocobalamin, ferrous fumarate, folic acid, nicotinamide, pyridoxine hydrochloride, retinol acetate, riboflavin, thiamine mononitrate, tocopheryl acetate, zinc oxide (PRENATAL VITAMINS), vitamin d nos (VITAMIN D), olopatadine hydrochloride (PATADAY), zinc sulfate (ZINC), ascorbic acid. Patient previously received BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EL1283 and expiry date was not reported), via an unspecified route of administration, in left arm on 29Jan2021 at 04:15 PM, as dose 1, single (Age at vaccination: 32 years) for COVID-19 immunization. The patient did not receive any other vaccine in four weeks. The patient was not diagnosed with COVID prior vaccination. The patient was not tested for COVID post vaccination. On 19Feb2021 at 6:00 AM, the patient experienced arm pain for 7 days post injection, severe headache, nausea, fatigue, headache lasting longer than 7 days on and off post injection (has not resolved yet, which is very concerning). Day 12 post second injection and the patient still experiencing severe throbbing headache, Dizziness on 19Feb2021 at 15:00 PM and armpit pain starting at 6 days post injection on 23Feb2021. The AE resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive treatment for the events. Outcome of the events were not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: armpit pain starting at 6 days post; dizziness; Arm pain x 7 days post-injection; severe headache; nausea; fatigue; This is a spontaneous report from a contactable pharmacist (patient, self-reported). A 32-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EL9263 and expiry date was not reported), via an unspecified route of administration, in Arm Left, on 18Feb2021 at 16:30 PM, as dose 2, single for COVID-19 immunization at hospital (Age at vaccination: 32 years). The patient was not pregnant at the time of vaccination. The patient medical history included exercise-induced bronchospasm, depression, anxiety and Past drug event with tetracycline and experienced rash. Concomitant medications included ascorbic acid, betacarotene, calcium sulfate, colecalciferol, cyanocobalamin, ferrous fumarate, folic acid, nicotinamide, pyridoxine hydrochloride, retinol acetate, riboflavin, thiamine mononitrate, tocopheryl acetate, zinc oxide (PRENATAL VITAMINS), vitamin d nos (VITAMIN D), olopatadine hydrochloride (PATADAY), zinc sulfate (ZINC), ascorbic acid. Patient previously received BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EL1283 and expiry date was not reported), via an unspecified route of administration, in left arm on 29Jan2021 at 04:15 PM, as dose 1, single (Age at vaccination: 32 years) for COVID-19 immunization. The patient did not receive any other vaccine in four weeks. The patient was not diagnosed with COVID prior vaccination. The patient was not tested for COVID post vaccination. On 19Feb2021 at 6:00 AM, the patient experienced arm pain for 7 days post injection, severe headache, nausea, fatigue, headache lasting longer than 7 days on and off post injection (has not resolved yet, which is very concerning). Day 12 post second injection and the patient still experiencing severe throbbing headache, Dizziness on 19Feb2021 at 15:00 PM and armpit pain starting at 6 days post injection on 23Feb2021. The AE resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive treatment for the events. Outcome of the events were not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm where vaccine was administered; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 37-years-old non-pregnant female patient received first dose of BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number EL3247), via an unspecified route of administration, administered in Arm Left on 23Feb2021 as single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient had no COVID prior to vaccination and was not tested for COVID. On 23Feb2021, the patient experienced sore arm where vaccine was administered. The patient did not receive any treatment for adverse event. The event outcome was recovered on an unspecified date.   Follow-up (14May2021): Follow-up attempts completed. No further information expected.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, Dizziness, Headache, Nausea
Clinical narrative: Stomach Cramps; headache; Nausea; Dizziness; This is a spontaneous report from a contactable consumer (patient). A 51-year-old male patient received bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, solution for injection), dose 1 via an unspecified route of administration, administered in left arm on 23Feb2021 13:45 (at the age of 51-year-old) (Batch/Lot Number: EL 3247) as DOSE 1, SINGLE for covid-19 immunization. Medical history included cardiovascular disease. Concomitant medications included Lipitor 40 Mg (LIPITOR [ATORVASTATIN CALCIUM]), Clopidogrel-75 mg (CLOPIDOGREL), Advil-400 Mg (ADVIL [IBUPROFEN]), Aspirin-81 Mg (ASPIRIN [ACETYLSALICYLIC ACID]) and Metoprolol-25 Mg (METOPROLOL) where all were taken for an unspecified indication, start and stop date were not reported. The patient had no known allergies. Patient did not received any other vaccines within 4 weeks to the COVID vaccine. On 24Feb2021 the patient experienced stomach cramps, headache, nausea and dizziness. Where the patient experienced the mentioned symptoms on the second day, and the symptoms got reduced on the day 3 after vaccination. Where the patient received regular medications post vaccination. Patient did not received treatment for the events. The patient was not tested positive for covid 19 prior to vaccination and had not been tested post vaccination. Outcome of all the events was recovering.   Follow-up attempts are completed. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Musculoskeletal stiffness
Clinical narrative: muscle stiffness from injection site up through shoulder and neck on left side; This is a spontaneous report from a contactable other HCP. This 44-Year-Old non-pregnant Female Other HCP (patient) reported for herself that she received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EL3247), via an unspecified route of administration, administered in arm left on 23Feb2021 11.15 (at the age of 44-years) as dose 1, single for covid-19 immunization. The patient relevant medical history asthma. Patient had known allergies sunflower seeds and topical steroids. Concomitant medication(s) included progesterone taken for birth control, start and stop date were not reported taken prior two weeks and montelukast sodium (SINGULAIR) taken for an unspecified indication, start and stop date were not reported. Patient did not receive any other vaccines prior to the COVID vaccine. The patient did not test for covid post vaccination. On an 23Feb2021 20:00, the patient experience muscle stiffness from injection site up through shoulder and neck on left side. The patient did not receive any treatment for adverse event. The outcome of the event was recovered on an unspecified date of 2021.     Follow-up attempts completed. No further information expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Fatigue, Musculoskeletal stiffness, Nausea
Clinical narrative: loss of appetite; injection site soreness; lower body soreness/stiffness; Lower body soreness/stiffness; nausea; chills; fatigue; This is a spontaneous report from a contactable consumer or other non hcp. A 38-years-old non-pregnant female patient received bnt162b2 (PFIZER BIONTECH COVID 19 VACCINE, Formulation: solution for injection, Batch/Lot Number: EL 3247) via an unspecified route of administration, administered in Arm Left on 23Feb2021 at 09:30 as dose 2, single (age at vaccination 38 years old) covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient had no known allergies. The patient had not received any other vaccine in four weeks. The patient had not received any other medications in two weeks. The patient had not diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 since the vaccination. Historical vaccine included bnt162b2 (PFIZER BIONTECH COVID 19 VACCINE, Formulation: solution for injection, Batch/Lot Number: EL 3247) via an unspecified route of administration, administered in Arm Left on 03Feb2021 09:30 as dose 1, single (age at vaccination 38 years old) for covid-19 immunisation. On 24Feb2021 at 09:00 patient experienced loss of appetite, injection site soreness, lower body soreness/stiffness, nausea, chills and fatigue. The patient did not received treatment for adverse events. The outcome of events was recovered on an unspecified day in 2021.  Follow-up attempts completed. No further information expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Vaccination site pain
Clinical narrative: loss of appetite; injection site soreness; lower body soreness/stiffness; Lower body soreness/stiffness; nausea; chills; fatigue; This is a spontaneous report from a contactable consumer or other non hcp. A 38-years-old non-pregnant female patient received bnt162b2 (PFIZER BIONTECH COVID 19 VACCINE, Formulation: solution for injection, Batch/Lot Number: EL 3247) via an unspecified route of administration, administered in Arm Left on 23Feb2021 at 09:30 as dose 2, single (age at vaccination 38 years old) covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient had no known allergies. The patient had not received any other vaccine in four weeks. The patient had not received any other medications in two weeks. The patient had not diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 since the vaccination. Historical vaccine included bnt162b2 (PFIZER BIONTECH COVID 19 VACCINE, Formulation: solution for injection, Batch/Lot Number: EL 3247) via an unspecified route of administration, administered in Arm Left on 03Feb2021 09:30 as dose 1, single (age at vaccination 38 years old) for covid-19 immunisation. On 24Feb2021 at 09:00 patient experienced loss of appetite, injection site soreness, lower body soreness/stiffness, nausea, chills and fatigue. The patient did not received treatment for adverse events. The outcome of events was recovered on an unspecified day in 2021.  Follow-up attempts completed. No further information expected.
Sex: M
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: a little tired; This is a spontaneous report from a contactable consumer or other non hcp. This case is for husband's first dose. A 89-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: Unknown, NDC/UPC number, Expiry date: unknown) via an unspecified route of administration on (age at vaccination: 89-year-old) as DOSE 1, SINGLE for COVID-19 immunisation. Medical history included diabetes from an unknown date and unknown if ongoing. Concomitant medication(s) included vitamin C [ascorbic acid] (VITAMIN C [ASCORBIC ACID]) 1000 mg daily, aspirin [acetylsalicylic acid] (ASPIRIN [ACETYLSALICYLIC ACID]) (81, three times a week), nicotinamide (VITAMIN B3) 2000 units, dutasteride (on Monday and Thursday), gabapentin 2.5 mg, daily, lisinopril, repaglinide one half mg at breakfast, atorvastatin calcium (LIPITOR [ATORVASTATIN CALCIUM]) 10mg daily, and hydroxocobalamin acetate (VITAMIN B12 [HYDROXOCOBALAMIN ACETATE]) all the medication taken for an unspecified indication from an unspecified start date and ongoing. It was reported that last week except a little tired, 3 weeks ago for the first one and I'm perfectly fine I feel chilled like for 2 hours and that's all, but he is much better today but I want to make sure I read the book that they gave me and I want to make sure that it's just a side effect and that he will get better." Reporter stated, Lab test was done few months ago and it was normal. The outcome of the event was unknown.  No follow-up attempts possible. No further information expected.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: a little tired; This is a spontaneous report from a contactable consumer. This female consumer reported for herself. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection, Lot Number: EN6203), dose 2 via an unspecified route of administration on 20Feb2021 13:20 as a single dose for covid-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced a little tired on Feb2021. Outcome of the event was not recovered. No Follow-up attempts are possible. Information about lot/batch cannot be obtained.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Dizziness, Headache, Incontinence
Clinical narrative: chills; headache; dizziness; diarrhea; incontinence; This is a spontaneous report from a contactable consumer (patient). A 71-years-old female patient first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EN6200 and expiry date was not reported), via an unspecified route of administration, on 20Feb2021 (age at vaccination: 71 years), as dose 1, single dose for COVID-19 immunization at hospital and acetylsalicylic acid (NUPRIN, lot number: 9GRO711, expiry date: May2021) for an unspecified indication. The patient's medical history included diabetes, asthma (she used an Inhaler), Covid-19 (she also reports having had Covid19 infection in January) in Jan2021. Concomitant medication included semaglutide (OZEMPIC). The patient reported that on Sunday, 21Feb2021, she had normal chills, dizziness, a horrible headache, diarrhea, and incontinence "all day long" and stated it was a "horrible 18 hours" and, she couldn't she went to, she peed on herself all day. She hadn't seen incontinence listed anywhere, and she's hesitant to get her second shot due to her experience after receiving the first. She also reported having had Covid19 infection in January and asked were these normal reactions and should she get the second dose. The patient wanted to know what would happen if she didn't get the second dose and should she get an antibody test. Maybe she "has too many antibodies" since she has a recent Covid19 infection in January. The second dose was due on 13Mar2021. There was a Product Complaint and description of product complaint included the patient stated for the headache she did, it didn't help at all she still have some headache this week she didn't, it's Tylenol. Product details (NDC# UPC#): consumer stated, " Yes, you want all of that? You want me to give you all those numbers? I am not doing that." Outcome of the event chills was unknown and for all other events, it was recovered on 21Feb2021.  No follow-up attempts are possible. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: muscle pain at injection site; This is a spontaneous report from a contactable consumer (patient). A 44-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot number was EL3247 and expiration date was not reported), via an unspecified route of administration, administered in left arm on 24Feb2021 at 14:30 (age at vaccination 44 years) as dose 1, single for COVID-19 immunization. Medical history included Known allergies: sulfa drugs from an unknown date and unknown if ongoing known allergies was sulfa drugs. The patient was not diagnosed with COVID-19 prior to vaccination. The patient's concomitant medications were not reported. On 24Feb2021 at 16:00 the patient experienced muscle pain at injection site. Since vaccination the patient was not tested for COVID-19. The patient took ibuprofen as therapeutic measures for muscle pain at injection site. The patient was recovered from the event on an unspecified date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Joint range of motion decreased, Vaccination site pain
Clinical narrative: reduced ROM in left shoulder; Pain at injection site; This is a spontaneous report from a contactable Consumer or other non-HCP (patient). A 24-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EN6201), via an unspecified route of administration, administered in Arm Left on 26Feb2021 at 12:45 (at the age of 24 years), as DOSE 1, SINGLE for COVID-19 immunization. The patient also received apremilast (OTEZLA, Batch/Lot number was not reported), oral from an unspecified date to an unspecified date, at 30 mg, BID for an unspecified indication. The patient medical history included Psoriasis. The patient concomitant medications were not reported. The patient did not take other vaccine in four weeks. Other medications taken in two weeks included Otezla 30mg PO BID. The patient did not have COVID prior vaccination. The patient did not test for COVID post vaccination. On 26Feb2021 at 13:00, the patient experienced reduced ROM in left shoulder and pain at injection site. The patient did not receive treatment for the events. The outcome of the events was not resolved at the time of this report.  No follow up attempts are needed. Information on lot/batch cannot be requested. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Appetite disorder, Taste disorder
Clinical narrative: seemed like a roller coaster ride with his taste buds and appetite; seemed like a roller coaster ride with his taste buds and appetite; This is a spontaneous report from a contactable consumer. This male consumer (patient) reported for himself that:  A male patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported, Expiry date was not reported) via an unspecified route of administration on 04Feb2021 as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Patient second dose for Pfizer COVID-19 vaccine was on Thursday in (withheld). Patient had first dose on 04Feb2021 and does not had breakfast the morning first shot he had and wondering if any precautions need to be taken in the morning of getting second shot. After first shot patient seem like roller coaster ride with taste buds and appetite in Feb2021. The clinical outcome of the events was unknown.   Follow-up attempts completed. No further information expected.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Body temperature decreased, Fatigue, Malaise
Clinical narrative: overtired; doesn't feel well; temperature is a little below normal; This is a spontaneous report from a contactable consumer (patient).  A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number: not reported) via an unspecified route of administration on 04Feb2021 as DOSE 1, SINGLE for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced overtired, did not feel well, and temperature was a little below normal on an unspecified date in Feb2021. The patient reported that she woke up that morning after she slept late as of reporting day, though it started last night. She reported that it happens sometimes that she was overtired, like a 24-hour thing, where she did not feel well and did not have a fever, actually her temperature was a little below normal, she took it. She says as the day has gone on, she was feeling a little better. She had waited on hold to ask a question of if she was not feeling well, should she not get the vaccine. The patient had her first shot already and was supposed to go get the second that Thursday on 25Feb202 at 13:45PM. The patient also reported that she might go to get the vaccine, anyway, just go on Thursday and explain to them when she got there if she was not feeling well. She had no fever, but she was feeling tired. Outcome of the events was unknown.  The lot and batch number for the vaccine BNT162B2 was not provided and will be requested during follow up.
Sex: U
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Malaise, Oropharyngeal pain
Clinical narrative: Tiredness; Headache; Chills; Sore throat; don't feel well; This is a spontaneous report from a contactable consumer (Patient). A patient of unspecified age and gender received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/lot number: Unknown, Expiry Date: Unknown) via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for COVID-19 immunization. The patient medical history and concomitant medications were not reported. It was reported that on an unspecified date patient experienced tiredness, headaches, chills, sore throat and don't feel well. Reporter stated he had the first shot of the Pfizer Covid injection, and he was having some of the symptoms, that are listed on the paper they gave him, the after effect and it had been 6 days that he had the shot, and these symptoms were seems to not go away. He was wondering how long he should wait before some these side effects go away. Outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Blood pressure increased, Blood pressure measurement
Clinical narrative: The blood pressure went up after they took the shot; I had my second dose on the 9th of February, it keeps going up; This is a spontaneous report from a contactable consumer(patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported), via an unspecified route of administration on 09Feb2021 as DOSE 2, SINGLE for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The historical vaccine include bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported), via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for COVID-19 immunisation. The patient experienced the blood pressure went up after they took the shot and had the second dose on the 9th of February, it keeps going up on an unspecified date. Reporter wanted to know does anyone reported that the blood pressure went up after they took the shot (Covid-19 Vaccine) had the Pfizer shot. The patient underwent lab test and procedures and found blood pressure increased. The event outcome was reported as unknown.   Follow-up attempts are completed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Rash macular, Skin disorder
Clinical narrative: blotches and lumps all around the face; blotches and lumps all around the face; This is a spontaneous report from a non-contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose number unknown, single for COVID-19 immunisation. The patient's medical history was not reported. The patient's concomitant medications included antihistamines. The patient experienced blotches and lumps all around the face on an unspecified date. The outcome of events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: I had a mild headache; it comes and goes; This is a spontaneous report from a contactable consumer(patient). A 65-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL3249) via an unspecified route of administration on 05Feb2021 (at the age of 65-years old) as DOSE 1, SINGLE for covid-19 immunisation. Patient Medical history included thyroid, Acid reflux. Concomitant medication included pantoprazole (PANTOPRAZOLE) taken for gastrooesophageal reflux disease, pravastatin (PRAVASTATIN), levothyroxine (LEVOTHYROXINE) taken for thyroid disorder. Patient had a mild headache for like 2 and half weeks and supposed to get another vaccine this Friday. Patient would like to postpone it because of the headache but can't get a hold of them and was wondering. Patient still experiencing the event it comes and goes and it is mild, patient have not taken Aspirin every day, it's just there. Patient have taken Tylenol couple of time but don't want to take that every day. The outcome of the event was not recovered.  Follow-up attempts completed. No further information expected.
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Hypertension
Clinical narrative: blood pressure is extremely high after receiving the Covid vaccine. My mother and sister also are having the same after receiving the vaccine; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as DOSE NUMBER UNKNWON, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The reporter stated that my blood pressure was extremely high after receiving the Covid vaccine. My mother and sister also were had the same after receiving the vaccine. The patient underwent lab tests and procedures which included blood pressure measurement: extremely high on an unspecified date. The outcome was unknown for the event.  Follow-up attempts completed. No further information expected.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: She is having a little fatigue problem; This is a spontaneous report from a contactable consumer. This consumer (husband) reported for a female patient (wife) that:  A female patient of an unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 Vaccine, solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date as dose 2, single for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. Historical vaccine includes first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 Vaccine, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization. On an unspecified date, the patient experienced fatigue. Reporter's wife got the second dose of COVID-19 Vaccine on Sunday. The patient is having a little fatigue problem. The outcome of the event was unknown.    No follow-up attempts are possible. Information about lot/ batch no cannot be requested.